Galera Therapeutics, Inc.
SEC CIK 1563577 · GRTX · last insider filing 2026-05-29
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Chang Nancy T | Director | filed 2025 - 2026 |
| Friedman Michael R. | Director | filed 2025 - 2026 |
| Sorensen Mel | Director · President and CEO | filed 2019 - 2025 |
| Lokay Kevin G | Director | filed 2019 - 2025 |
| Alleva Lawrence M | Director | filed 2019 - 2025 |
| West Linda | Director | filed 2020 - 2023 |
| Powell Michael | Director | filed 2019 - 2023 |
| Cunningham Emmett | Director | filed 2019 - 2023 |
| Fuller Jason | Director | filed 2019 - 2019 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Sussman Joel F. | Chief Accounting Officer | filed 2019 - 2025 |
| Bachleda Mark | Chief Commercial Officer | filed 2021 - 2023 |
| Degnan Chris | Chief Financial Officer | filed 2019 - 2023 |
| Beardsley Robert A | Chief Operating Officer | filed 2019 - 2023 |
| Stacey Jennifer Evans | See Remarks | filed 2021 - 2023 |
| Kennedy Eugene P. | Chief Medical Officer | filed 2022 - 2023 |
| Holmlund JON T | Chief Medical Officer | filed 2019 - 2022 |
| Fratamico Arthur | Chief Business Officer | filed 2019 - 2021 |
| Riley Dennis | Chief Scientific Officer | filed 2019 - 2020 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.